0001831908-22-000002.txt : 20220106 0001831908-22-000002.hdr.sgml : 20220106 20220106165906 ACCESSION NUMBER: 0001831908-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220106 DATE AS OF CHANGE: 20220106 EFFECTIVENESS DATE: 20220106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pluto Immunotherapeutics, Inc. CENTRAL INDEX KEY: 0001831908 IRS NUMBER: 845089227 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-428232 FILM NUMBER: 22515456 BUSINESS ADDRESS: STREET 1: 907 WESTWOOD BLVD, STE 1086 CITY: LOS ANGELES STATE: CA ZIP: 90024 BUSINESS PHONE: 818-314-1910 MAIL ADDRESS: STREET 1: 907 WESTWOOD BLVD, STE 1086 CITY: LOS ANGELES STATE: CA ZIP: 90024 D 1 primary_doc.xml X0708 D LIVE 0001831908 Pluto Immunotherapeutics, Inc. 570 WESTWOOD PLAZA LOS ANGELES CA CALIFORNIA 90095 818-314-1910 DELAWARE None None Corporation true 2020 Mark Cohen Times Square Tower, 7 Times Square Floor 19 New York NY NEW YORK 10036 Director Chairman of the Board Gay Crooks 570 Westwood Plaza Los Angeles CA CALIFORNIA 90095 Director Amelie Montel-Hagen 570 Westwood Plaza Los Angeles CA CALIFORNIA 90095 Executive Officer Director Director and Chief Scientific Officer Christopher Seet 570 Westwood Plaza Los Angeles CA CALIFORNIA 90095 Director Biotechnology Decline to Disclose 06b false 2021-12-22 false true Simple Agreement for Future Equity (SAFE) false 10000 3000000 2766753 233247 false 20 0 0 0 false Pluto Immunotherapeutics, Inc. /s/ Mark Cohen Mark Cohen Chairman of the Board 2022-01-06